Abstract:Complex genetic and physiological variations as well as environmental factors that drive emergence of chromosomal instability, development of unscheduled cell death, skewed differentiation, and altered metabolism are central to the pathogenesis of human diseases and disorders. Understanding the molecular bases for these processes is important for the development of new diagnostic biomarkers, and for identifying new therapeutic targets. In 1973, a group of non-histone nuclear proteins with high electrophoretic mobility was discovered and termed high-mobility group (HMG) proteins. The HMG proteins include three superfamilies termed HMGB, HMGN, and HMGA. High-mobility group box 1 (HMGB1), the most abundant and well-studied HMG protein, senses and coordinates the cellular stress response and plays a critical role not only inside of the cell as a DNA chaperone, chromosome guardian, autophagy sustainer, and protector from apoptotic cell death, but also outside the cell as the prototypic damage associated molecular pattern molecule (DAMP). This DAMP, in conjunction with other factors, thus has cytokine, chemokine, and growth factor activity, orchestrating the inflammatory and immune response. All of these characteristics make HMGB1 a critical molecular target in multiple human diseases including infectious diseases, ischemia, immune disorders, neurodegenerative diseases, metabolic disorders, and cancer. Indeed, a number of emergent strategies have been used to inhibit HMGB1 expression, release, and activity in vitro and in vivo. These include antibodies, peptide inhibitors, RNAi, anti-coagulants, endogenous hormones, various chemical compounds, HMGB1-receptor and signaling pathway inhibition, artificial DNAs, physical strategies including vagus nerve stimulation and other surgical approaches. Future work further investigating the details of HMGB1 localization, structure, post-translational modification, and identification of additional partners will undoubtedly uncover additional secrets regarding HMGB1's multiple functions.

The multifunctional protein HMGB1: 50 years of discovery

HMGB1 in health and disease

High Mobility Group Box 1: Biological Functions and Relevance in Oxidative Stress Related Chronic Diseases

The mechanism of HMGB1 secretion and release

HMGB1 as a therapeutic target in disease

HMGB1 in Cancer: Good, Bad, or Both?

HMGB1: guiding immunity from within

The Janus face of HMGB1 in heart disease: a necessary update

Multiple functions of HMGB1 in cancer

HMGB1, an evolving pleiotropic protein critical for cellular and tissue homeostasis: role in aging and age-related diseases

HMGB1: An overview of its roles in the pathogenesis of liver disease

Dual faced HMGB1 plays multiple roles in cardiomyocyte senescence and cardiac inflammatory injury

Post-Translational Modification of HMGB1 Disulfide Bonds in Stimulating and Inhibiting Inflammation

HMGB1 as a DNA-binding cytokine

HMGB1, a novel inflammatory cytokine

Deciphering HMGB1: Across a spectrum of DNA and nucleosome dynamics

HMGB1 in inflammation and cancer

Immunological Significance of HMGB1 Post-Translational Modification and Redox Biology

The redox protein HMGB1 in cell death and cancer

The Effect and Regulatory Mechanism of High Mobility Group Box-1 Protein on Immune Cells in Inflammatory Diseases

HMGB1 in kidney diseases